Biotay
Date: Sep 2017
Client: Biotay
Counterparty: Phibro Animal Health
Industry: Healthcare
Amount: Undisclosed amount
Transaction:
Landmark Alantra advised the shareholders of Biotay on the sale of 100% of the shares to Phibro Animal Health.
Biotay S.A. is a leading Argentine animal health and nutritional products company engaged in production, marketing and distribution within Argentina. The company specializes in bovine cattle, swine and poultry segments, and to a lesser extent horses and other species. Phibro (NASDAQ:PAHC) is a global developer, manufacturer and marketer of animal health and mineral nutrition products for the poultry, swine, dairy, cattle and aquaculture markets. PAHC’s revenues and EBITDA reached US$764 million and US$150 million in LTM June-2017, respectively.
Sep 2017
Financial advisor to
on the sale of 100% of the shares to
Undisclosed amount
Similar transactions
Nov 2021
Financial advisor to
on the sale of 34% of the shares to
With this transaction, Virbac completes the acquisition of 100% of the company since the initial purchase in 2012
Leer más
